BioCryst Pharmaceuticals
BCRX
#4588
Rank
โ‚น233.38 B
Marketcap
โ‚น918.24
Share price
0.96%
Change (1 day)
24.82%
Change (1 year)

Number of shares outstanding for BioCryst Pharmaceuticals (BCRX)

Number of shares outstanding as of July 2026 : 242,258,000

According to BioCryst Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 242,258,000. At the end of 2026 the company had 242,258,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for BioCryst Pharmaceuticals from 1996 to 2026

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20260.24 B14.83%
20250.21 B1.73%
20240.20 B2.97%
20230.20 B7.75%
20220.18 B2.79%
20210.18 B2.96%
20200.17 B34.51%
20190.13 B19.58%
20180.10 B11.59%
201798.4 M33.4%
201673.76 M0.57%
201573.34 M2.06%
201471.86 M21.62%
201359.09 M16.13%
201250.88 M12.63%
201145.17 M0.66%
201044.88 M16.7%
200938.46 M0.96%
200838.09 M11.14%
200734.27 M17.3%
200629.22 M11.5%
200526.2 M20.75%
200421.7 M22.74%
200317.68 M0.2%
200217.65 M0.48%
200117.56 M0.24%
200017.52 M15.9%
199915.11 M6.39%
199814.21 M2.32%
199713.88 M27.78%
199610.86 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Gilead Sciences
GILD
1,242,000,000 412.68%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,011,500,000 730.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
104,988,000-56.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
56,354,000-76.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
163,276,000-32.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
66,566,000-72.52%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
21,609,488-91.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
8,138,233-96.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
51,900,000-78.58%๐Ÿ‡บ๐Ÿ‡ธ USA